Hodgkin's lymphoma in developing countries: can we go further?☆

Abstract

42.7%; 95% confidence interval: 27.5–57.9). Noteworthy, the odgkin’s lymphoma (HL) is a B cell malignancy that affects pproximately 8000 new patients in the United States nnually.1 This is the most common lymphoma affecting he young population with a higher incidence at ages 15 to 5 years. Because of its particular histological features and iological… (More)
DOI: 10.1016/j.bjhh.2017.08.004

Topics

Cite this paper

@inproceedings{Gaiolla2017HodgkinsLI, title={Hodgkin's lymphoma in developing countries: can we go further?☆}, author={Rafael Dezen Gaiolla}, booktitle={Revista brasileira de hematologia e hemoterapia}, year={2017} }